The Nasdaq and S&P 500 have clawed their way into positive territory
The Nasdaq Composite (IXIC) is clawing its way out of red territory this afternoon, as Big Tech attempts to rebound. The S&P 500 Index (SPX) has also pivoted higher despite rampant rate cut concerns, with investors now only pricing in a 51% chance of a quarter-point interest rate cut in December, per CME's FedWatch Tool. The Dow Jones Industrial Average (DJI) is sitting out the late-week rally, extending yesterday's steep losses. Despite the general angst on Wall Street lately, all three major indexes have a chance to eke out weekly wins.
Continue reading for more on today's market, including:
- C-suite shakeup dings Walmart stock.
- Chip stock brushes off upbeat quarter.
- Plus, options traders target AIG; DASH bounces back; and pharma stock halts late-stage trial.
American International Group Inc (NYSE:AIG) stock is down 0.9% to trade at $77.58 at last check, after the insurance company noted in a SEC filing that it will work on its future organizational structure. AIG is seeing unusual options activity today, with 4,230 calls and 4,036 puts traded so far -- volume that is nine times the amount typically seen at this point. Most active is the June 80 call, where new positions are being bought to open. AIG sports a 6.7%
year-to-date lead.
DoorDash Inc (NASDAQ:DASH) stock is leading the SPX today, last seen up 5.7% to trade at $206.31. The security is looking to snap a four-day losing streak with its biggest single-day percentage gain since April, following a dramatic pullback from its Oct. 16, all-time high of $285.35. The $200 region seems to have emerged as a floor.
The food delivery stock is now up 22.8% for 2025.
Bristol-Myers Squibb Co (NYSE:BMY) stock is pacing the SPX's laggards today, down 3.6% to trade at $46.86. Today's bear gap comes after the drugmaker stopped a late-stage trial with Johnson & Johnson (JNJ) of an experimental blood thinner for survivors of heart attacks, noting an independent review found it was unlikely to meet its primary goal. BMY has shed 19.5% in the last 12 months, and is pulling back from a rally to its
highest level since June.
